| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Resource center
Our commitment
Mayo Clinic Laboratories is committed to working with our communities as we all face the unprecedented challenges of the COVID-19 pandemic. Since early 2020, Mayo Clinic researchers and experts have provided expertise to guide the public health response, and our clinical staff has been on the front lines providing lifesaving care for patients with COVID-19.
Learn more about our COVID-19 testing.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
*Data current as of 4/1/22
6,417,638
molecular tests performed
9
COVID-19 testing platforms implemented
299,582
serology tests performed
24/7
support from Mayo Clinic physicians and scientists
COVID testing
Mayo Clinic Laboratories provides testing and associated support for our clients around the world as they manage the ongoing effects of COVID-19. We offer a comprehensive menu of COVID-19 and related testing, including molecular (PCR) testing to diagnose active COVID-19 infection; serology testing to identify people who previously had COVID-19 or have active immunity; and COVID-19/influenza multiplex testing.
Expertise
Mayo Clinic researchers and experts have played a key role in the global response to COVID-19 — from developing and deploying testing, to providing up-to-date information to the public, to advising government and businesses on the best ways to keep people safe.
Newsroom
Featuring Mayo Clinic Laboratories in the news, as well as the latest COVID-19 podcasts and articles. Keep up to date on testing developments and scientific advances.
COVID-19 focused podcasts
Mayo Clinic experts share their knowledge on the state of testing, vaccines, treatments, and more. Podcasts are hosted by Bobbi Pritt, M.D., chair of Mayo Clinic's Division of Clinical Microbiology.
Resources
Access COVID-19 resources, reference guides, educational content, FAQs, and more.
The Latest
In this episode, Dr. Pritt and Dr. Morice discuss the science behind the increasing COVID-19 infections, why individuals can get reinfected with different variants, and the effectiveness of the at-home antigen tests.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss advances in monkeypox testing, working with the CDC to scale testing and response efforts, the fast-spreading BA.5 variant of COVID-19, and how at-home testing affects the number of reported cases.
Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt Sause, president and CEO of Roche Diagnostics North America, explain how the well-intended Protecting Access to Medicare Act of 2014 (PAMA) puts vital diagnostic tests at risk.
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in developing and implementing new tests — but never on such an aggressive timeline.
PACE - In this month’s “Virtual Lecture,” William Morice, M.D., Ph.D., gives an overview of the national response to the need for COVID-19 testing at the onset of, and during, the pandemic.